Virus therapy takes on tough cancers in early trial
Disease control
Not yet recruiting
This early-stage study tests a new drug called OTS-412, made from a modified virus, alone or with other medicines in 24 adults whose solid tumors have stopped responding to standard treatments. The main goal is to check safety and side effects, while also seeing if the tumors shr…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated Jun 14, 2026 13:39 UTC